A critical discovery in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many kinds of cancer, causing https://todaybookmarks.com/story22107284/mini-antibodies-revive-p53-new-potential-hope-for-cancer-treatment